228 related articles for article (PubMed ID: 30215805)
1. Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Inflamm Bowel Dis; 2019 Feb; 25(3):592-600. PubMed ID: 30215805
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease.
Van Der Sloot KW; Joshi AD; Bellavance DR; Gilpin KK; Stewart KO; Lochhead P; Garber JJ; Giallourakis C; Yajnik V; Ananthakrishnan AN; Alizadeh BZ; Xavier RJ; Khalili H
Inflamm Bowel Dis; 2017 Jan; 23(1):82-88. PubMed ID: 27893544
[TBL] [Abstract][Full Text] [Related]
4. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
[TBL] [Abstract][Full Text] [Related]
5. Visceral adiposity predicts post-operative Crohn's disease recurrence.
Holt DQ; Moore GT; Strauss BJ; Hamilton AL; De Cruz P; Kamm MA
Aliment Pharmacol Ther; 2017 May; 45(9):1255-1264. PubMed ID: 28244124
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life.
Dai C; Jiang M; Huang YH
Inflamm Bowel Dis; 2019 May; 25(6):e61. PubMed ID: 30380063
[No Abstract] [Full Text] [Related]
7. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
[TBL] [Abstract][Full Text] [Related]
8. Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
Zittan E; Kelly OB; Kirsch R; Milgrom R; Burns J; Nguyen GC; Croitoru K; Van Assche G; Silverberg MS; Steinhart AH
Inflamm Bowel Dis; 2016 Mar; 22(3):623-30. PubMed ID: 26829408
[TBL] [Abstract][Full Text] [Related]
9. Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life.
Bryant RV; Schultz CG; Ooi S; Goess C; Costello SP; Vincent AD; Schoeman S; Lim A; Bartholomeusz FD; Travis SPL; Andrews JM
Inflamm Bowel Dis; 2019 May; 25(6):e62-e63. PubMed ID: 30380064
[No Abstract] [Full Text] [Related]
10. Visceral Adipose Tissue in Patients with Crohn's Disease Correlates with Disease Activity, Inflammatory Markers, and Outcome.
Büning C; von Kraft C; Hermsdorf M; Gentz E; Wirth EK; Valentini L; Haas V
Inflamm Bowel Dis; 2015 Nov; 21(11):2590-7. PubMed ID: 26222339
[TBL] [Abstract][Full Text] [Related]
11. A Nomogram Combining Fecal Calprotectin Levels and Plasma Cytokine Profiles for Individual Prediction of Postoperative Crohn's Disease Recurrence.
Cerrillo E; Moret I; Iborra M; Pamies J; Hervás D; Tortosa L; Sáez-González E; Nos P; Beltrán B
Inflamm Bowel Dis; 2019 Sep; 25(10):1681-1691. PubMed ID: 30925193
[TBL] [Abstract][Full Text] [Related]
12. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
13. Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery.
Wright EK; Kamm MA; De Cruz P; Hamilton AL; Ritchie KJ; Krejany EO; Leach S; Gorelik A; Liew D; Prideaux L; Lawrance IC; Andrews JM; Bampton PA; Jakobovits SL; Florin TH; Gibson PR; Debinski H; Macrae FA; Samuel D; Kronborg I; Radford-Smith G; Selby W; Johnston MJ; Woods R; Elliott PR; Bell SJ; Brown SJ; Connell WR; Day AS; Desmond PV; Gearry RB
Gastroenterology; 2015 May; 148(5):938-947.e1. PubMed ID: 25620670
[TBL] [Abstract][Full Text] [Related]
14. A pilot study of visceral fat and its association with adipokines, stool calprotectin and symptoms in patients with diverticulosis.
Murray KA; Hoad CL; Garratt J; Kaviani M; Marciani L; Smith JK; Siegmund B; Gowland PA; Humes DJ; Spiller RC
PLoS One; 2019; 14(5):e0216528. PubMed ID: 31067253
[TBL] [Abstract][Full Text] [Related]
15. Correlation between fecal calprotectin and inflammation in the surgical specimen of Crohn's disease.
Pous-Serrano S; Frasson M; Cerrillo E; Beltrán B; Iborra M; Hervás D; García-Granero E; Nos P
J Surg Res; 2017 Jun; 213():290-297. PubMed ID: 28601328
[TBL] [Abstract][Full Text] [Related]
16. A new rapid test for fecal calprotectin predicts endoscopic remission and postoperative recurrence in Crohn's disease.
Lobatón T; López-García A; Rodríguez-Moranta F; Ruiz A; Rodríguez L; Guardiola J
J Crohns Colitis; 2013 Dec; 7(12):e641-51. PubMed ID: 23810085
[TBL] [Abstract][Full Text] [Related]
17. Prediction of disease activity of Crohn's disease through fecal calprotectin evaluated by balloon-assisted endoscopy.
Iwamoto F; Matsuoka K; Motobayashi M; Takenaka K; Kuno T; Tanaka K; Tsukui Y; Kobayashi S; Yoshida T; Fujii T; Saito E; Yamaguchi T; Nagahori M; Sato T; Ohtsuka K; Enomoto N; Watanabe M
J Gastroenterol Hepatol; 2018 Dec; 33(12):1984-1989. PubMed ID: 29889986
[TBL] [Abstract][Full Text] [Related]
18. Body Composition Predictors of Complicated Crohn's Disease.
Barajas Ordonez F; Melekh B; Rodríguez-Feria P; Melekh O; Thormann M; Damm R; Omari J; Pech M; Surov A
Dig Dis; 2023; 41(4):589-599. PubMed ID: 36720207
[TBL] [Abstract][Full Text] [Related]
19. Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease.
Shaoul R; Sladek M; Turner D; Paeregaard A; Veres G; Wauters GV; Escher J; Dias JA; Lionetti P; Staino A; Kolho KL; de Ridder L; Nuti F; Cucchiara S; Sheva O; Levine A;
Inflamm Bowel Dis; 2012 Aug; 18(8):1493-7. PubMed ID: 22275268
[TBL] [Abstract][Full Text] [Related]
20. Level of Fecal Calprotectin Correlates With Severity of Small Bowel Crohn's Disease, Measured by Balloon-assisted Enteroscopy and Computed Tomography Enterography.
Arai T; Takeuchi K; Miyamura M; Ishikawa R; Yamada A; Katsumata M; Igarashi Y; Suzuki Y
Clin Gastroenterol Hepatol; 2017 Jan; 15(1):56-62. PubMed ID: 27565523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
